Analyst Price Targets — CANO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 6, 2023 7:55 am | — | UBS | $125.00 | $110.00 | Benzinga | UBS Downgrades Cano Health to Neutral, Lowers Price Target to $1.25 |
| November 16, 2022 7:46 am | — | Citigroup | $250.00 | $102.13 | Benzinga | Citigroup Maintains Buy on Cano Health, Lowers Price Target to $5 |
| May 10, 2022 12:00 am | Jason Cassorla | Citigroup | $480.00 | $247.50 | TipRanks Contributor | Despite Exceeding Q1 Expectations, Cano Health Shares Plunge 8.9% |
| April 20, 2022 7:04 am | — | UBS | $576.00 | $198.14 | Benzinga | UBS Initiates Coverage On Cano Health with Buy Rating, Announces Price Target of $15 |
| March 18, 2022 12:00 am | Gary Taylor | Cowen & Co. | $832.00 | $447.36 | Pulse 2.0 | Cano Health (CANO) Stock: $13 Price Target And Outperform Rating |
| January 14, 2022 12:00 am | Jason Cassorla | Citigroup | $960.00 | $520.80 | Pulse 2.0 | Cano Health Stock (CANO): $12 Price Target From Citi |
No recent news available for CANO.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CANO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.